Abstract:Percutaneous coronary interventions can treat conditions like atherosclerosis but outcomes may be complicated by neointimal hyperplasia (NIH). Thus, polymeric drug-eluting stents may serve as a treatment option to target NIH. Local release of anti-proliferative drugs can inhibit smooth muscle proliferation while polymer degradation allows for endothelial recovery. Here, we fabricated drug-loaded stents using the bioresorbable polymer polycaprolactone (PCL) infused with the immunosuppressant drug rapamycin. 12% PCL solutions were made by dissolving PCL in a 8:3 ratio of toluene to methanol. For drug loading, rapamycin was added to a final concentration of 3.63 mg/mL. Solutions were electrospun into nanofiber mats by Avecta’s Spraybase system with these parameters: 2 mL volume, 20-gauge needle, 4 mL/hr feed rate, 10 cm spray distance, 12 kV voltage, and 4 mm drum collector spun at 230 rpm. Stents were characterized by scanning electron microscopy (SEM) and tested for physicochemical properties. Stents were tested for hemocompatibility and cell attachment and cytotoxicity against endothelial cell line RF-24 and smooth muscle cell line MOVAS. Drug release kinetics were studied by quantifying eluted rapamycin. Cell growth was inhibited at drug concentrations of 0.03 mg/mL for MOVAS and 0.029 mg/mL for RF-24. PCL stents were 0.311 ± 0.069 μm in fiber diameter, 19.8 ± 14.1 μm2 in pore size, and 82.4% average porosity. Drug-loaded stents were 0.303 ± 0.080 μm in fiber diameter, 19.8 ± 14.7 μm2 in pore size, and 81.7% average porosity. SEM images revealed successful attachment onto all cell-seeded stents. Viability assays showed limited death for both cell lines. No significant hemolysis was observed. For drug-eluting stents, release was sustained over 28 days, achieving a theoretical cumulative release of 85.4% over 4 weeks. Rapamycin-eluting stents demonstrated in vitro biocompatibility and hemocompatibility with sustained drug release over 4 weeks. This suggests the potential of rapamycin-loaded PCL stents as novel candidates for vascular graft material and local drug delivery.

REDV/Rapamycin-loaded Polymer Combinations As a Coordinated Strategy to Enhance Endothelial Cells Selectivity for a Stent System.

Redv/Peptide Conjugated Rapamycin-Loaded Polymer Matrix for Endothelial Cells Selectivity

Identification of endothelial protein C receptor as a novel druggable agonistic target for reendothelialization promotion and thrombosis prevention of eluting stent

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation

A bio-inspired nanoparticle coating for vascular healing and immunomodulatory by cGMP-PKG and NF-kappa B signaling pathways

A Zwitterionic Hydrogel Coated Titanium Surface with High-Efficiency Endothelial Cell Selectivity for Rapid Re-Endothelialization.

Bioinspired NO Release Coating Enhances Endothelial Cells and Inhibits Smooth Muscle Cells

Abstract No. 437 Rapamycin-eluting Polymeric Stents for Biomedical Applications

A nitric oxide-eluting and REDV peptide-conjugated coating promotes vascular healing

[Pilot Study of a Cell Membrane Like Biomimetic Drug-Eluting Coronary Stent].

Biomimetic engineering endothelium-like coating on cardiovascular stent through heparin and nitric oxide-generating compound synergistic modification strategy

Selective endothelial cells adhesion to Arg-Glu-Asp-Val peptide functionalized polysaccharide multilayer

Covalent grafting of zwitterion polymer and REDV peptide onto NiTi alloy surface for anticoagulation and proendothelialization

Development of Mussel Adhesive Polypeptide Mimics Coating for In-Situ Inducing Re-Endothelialization of Intravascular Stent Devices

A Polymeric Strategy Empowering Vascular Cell Selectivity and Potential Application Superior to Extracellular Matrix Peptides.

Improve Endothelialization of Metallic Cardiovascular Stent Via Femtosecond Laser Induced Micro/nanostructure Dependent Cells Proliferation and Drug Delivery Control

Accelerated Endothelialization with a Polymer-Free Sirolimus-Eluting Antibody-Coated Stent.

Bioinspired Vascular Stents with Microfluidic Electrospun Multilayer Coatings for Preventing in‐stent Restenosis

Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.

A cell membrane like biomimetic drug-eluting coronary stent